<code id='1940C7DD99'></code><style id='1940C7DD99'></style>
    • <acronym id='1940C7DD99'></acronym>
      <center id='1940C7DD99'><center id='1940C7DD99'><tfoot id='1940C7DD99'></tfoot></center><abbr id='1940C7DD99'><dir id='1940C7DD99'><tfoot id='1940C7DD99'></tfoot><noframes id='1940C7DD99'>

    • <optgroup id='1940C7DD99'><strike id='1940C7DD99'><sup id='1940C7DD99'></sup></strike><code id='1940C7DD99'></code></optgroup>
        1. <b id='1940C7DD99'><label id='1940C7DD99'><select id='1940C7DD99'><dt id='1940C7DD99'><span id='1940C7DD99'></span></dt></select></label></b><u id='1940C7DD99'></u>
          <i id='1940C7DD99'><strike id='1940C7DD99'><tt id='1940C7DD99'><pre id='1940C7DD99'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:Wikipedia    Page View:8434
          John-Arne-Røttingen, a white man with short hair, smiles at the camera wearing blue suits — biotech coverage from STAT
          John-Arne Røttingen is the head of the Wellcome Trust, one of the world’s top private funders of biomedical research. Illustration: STAT; Source: Wellcome Trust

          LONDON — The key groups involved in addressing global health problems often include governments, foundations, and pharmaceutical companies.

          But to John-Arne Røttingen, the new head of the Wellcome Trust, one of the world’s top private funders of biomedical research, there’s another sector that should be getting involved — the tech industry.

          advertisement

          The Alphabets and Amazons of the world have been growing their health-related initiatives, but the industry is rarely mentioned when neglected public health issues are discussed, Røttingen argued.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          After affirmative action ruling, medical educators look to 'holistic review'
          After affirmative action ruling, medical educators look to 'holistic review'

          AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

          read more
          Eli Lilly buys Point Biopharma in radiopharmaceuticals play
          Eli Lilly buys Point Biopharma in radiopharmaceuticals play

          DarronCummings/APAcouplebillionhere,acouplebillionthere,andprettysoonEliLillyhopesitwillbetalkingabo

          read more
          New air purifier tech could be key to improving indoor air quality
          New air purifier tech could be key to improving indoor air quality

          AdobeUntiltheearly20thcentury,Americaregularlyexperiencedbrutallydestructiveurbanfires.Conflagration

          read more

          Physician executives need more than on

          AdobeItshouldbeobviousthatmedicalschoolandclinicalexperience,inthemselves,can’tfullypreparesomeonefo